4.0 Percent of Seniors Had Received Dementia Diagnosis in 2022
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, June 13, 2024 -- In 2022, 4.0 percent of adults aged 65 years and older reported ever having received a dementia diagnosis, with similar percentages seen for men and women, according to a study published online June 13 in the National Health Statistics Reports, a publication from the National Center for Health Statistics.
Ellen A. Kramarow, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, estimated the percentage of noninstitutionalized older adults (aged 65 years and older) with a dementia diagnosis using data from the 2022 National Health Interview Survey (NHIS).
Kramarow found that 4.0 percent of adults aged 65 years and older reported ever having received a dementia diagnosis in 2022, with the percentage similar for men and women (3.8 and 4.2 percent, respectively). There was an increase seen in the percentage of adults with a dementia diagnosis with age, from 1.7 to 13.1 percent for those ages 65 to 74 years and 85 years and older, respectively, while the percentage decreased with increasing education level, from 7.9 to 2.2 percent for those with less than a high school diploma and with a college degree or higher, respectively.
"Early detection and diagnosis of dementia is an important public health strategy as it allows patients and their families to plan for future needs," Kramarow writes. "Data from NHIS can be used to track progress towards these goals."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-14 07:15
Read more
- Ultraprocessed Food Intake Accounts for More Than Half of Kids’ Energy Intake
- Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
- Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications
- Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
- IDSA: MVA-BN Vaccine Against Mpox Tolerated, Effective for Teens
- Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions